| NME | Egaten | triclabendazole | To treat fascioliasis, a parasitic infestation caused by two species of flatworms or trematodes that mainly the affect the liver, sometimes referred to as “liver flukes” | | Drug Trials Snapshot | 2019/02/13 | NOVARTIS PHARMS CORP |
| Biologics | Cablivi | caplacizumab-yhdp | To treat adult patients with acquired thrombotic thrombocytopenic purpura (aTTP) | Press Release | Drug Trials Snapshot | 2019/02/06 | ABLYNX NV |
| Biologics | JEUVEAU | PRABOTULINUMTOXINA-XVFS | For the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients | | Drug Trials Snapshot | 2019/02/01 | EVOLUS INC |
| Biologics | Ultomiris | ravulizumab | To treat paroxysmal nocturnal hemoglobinuria (PNH) | Press Release | Drug Trials Snapshot | 2018/12/21 | ALEXION PHARM |
| Biologics | Elzonris | tagraxofusp-erzs | To treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) | Press Release | Drug Trials Snapshot | 2018/12/21 | STEMLINE THERAPEEUTICS INC |
| Biologics | Asparlas | calaspargase pegol-mknl | To treat acute lymphoblastic leukemia (ALL) in pediatric and young adult patients age 1 month to 21 years | | Drug Trials Snapshot | 2018/12/20 | SERVIER PHARMA LLC |
| NME | Motegrity | prucalopride | To treat chronic idiopathic constipation | | Drug Trials Snapshot | 2018/12/14 | SHIRE DEV LLC |
| NME | Xospata | gilteritinib | To treat patients who have relapsed or refractory acute myeloid leukemia (AML) | Press Release | | 2018/11/28 | ASTELLAS |
| NME | Firdapse | amifampridine | To treat Lambert-Eaton myasthenic syndrome (LEMS) in adults | Press Release | | 2018/11/28 | CATALYST PHARMA INC |
| NME | Vitrakvi | larotrectinib | To treat patients whose cancers have a specific genetic feature (biomarker) | Press Release | | 2018/11/26 | LOXO ONCOLOGY INC |
| NME | Daurismo | glasdegib | To treat newly-diagnosed acute myeloid leukemia (AML) in adult patients | Press Release | | 2018/11/21 | PFIZER INC |
| Biologics | Gamifant | emapalumab-lzsg | To treat primary hemophagocytic lymphohistiocytosis (HLH) | Press Release | | 2018/11/20 | NOVIMMUNE S.A. |
| NME | Aemcolo | rifamycin | To treat travelers’ diarrhea | Press Release | Drug Trials Snapshot | 2018/11/16 | COSMO TECHNOLOGIES LTD |
| NME | Yupelri | revefenacin | To treat patients with chronic obstructive pulmonary disease (COPD) | | Drug Trials Snapshot | 2018/11/08 | THERAVANCE BIOPHARMA |
| NME | Lorbrena | loratinib | To treat patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer | | | 2018/11/02 | PFIZER INC |
| NME | Xofluza | baloxavir marboxil | For the treatment of acute uncomplicated influenza in patients who have been symptomatic for no more than 48 hours. | Press Release | Drug Trials Snapshot | 2018/10/24 | SHIONOGI INC |
| NME | Talzenna | talazoparib | For the treatment of locally advanced or metastatic breast cancer patients with a germline BRCA mutation. | | Drug Trials Snapshot | 2018/10/16 | PFIZER INC |
| NME | Tegsedi | inotersen | To treat polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults | | Drug Trials Snapshot | 2018/10/05 | IONIS PHARMS INC |
| Biologics | Revcovi | elapegademase-lvlr | To treat Adenosine Deaminase-Severe Combined Immunodeficiency (ADA-SCID) | | Drug Trials Snapshot | 2018/10/05 | LEADIANT BIOSCI INC |
| NME | Nuzyra | omadacycline | To treat community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections | | Drug Trials Snapshot | 2018/10/03 | PARATEK PHARMS INC |
